VIMTA LABS
Back to Balance Sheet
|
VIMTA LABS Last 5 Year Total Liabilities History
[Consolidated]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹392 Cr | ₹358 Cr | ₹305 Cr | ₹273 Cr | ₹245 Cr |
What is the latest Total Liabilities ratio of VIMTA LABS ?
| Year | Total Liabilities |
|---|---|
| Mar2024 | ₹392 Cr |
| Mar2023 | ₹358 Cr |
| Mar2022 | ₹305 Cr |
| Mar2021 | ₹273 Cr |
| Mar2020 | ₹245 Cr |
How is Total Liabilities of VIMTA LABS Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2024 | ₹392 Cr | 9.56 | |
| Mar2023 | ₹358 Cr | 17.33 | |
| Mar2022 | ₹305 Cr | 11.61 | |
| Mar2021 | ₹273 Cr | 11.47 | |
| Mar2020 | ₹245 Cr | - | |
Compare Total Liabilities of peers of VIMTA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VIMTA LABS | ₹1,999.2 Cr | 9% | -27.6% | 5.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,847.0 Cr | 6.8% | -1.5% | -2.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,745.0 Cr | 0% | -4.8% | 8.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,346.0 Cr | 1.7% | 4.1% | 20.5% | Stock Analytics | |
| CIPLA | ₹107,075.0 Cr | 0.1% | -12.8% | -9.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,507.0 Cr | 1.8% | -0.7% | 3.4% | Stock Analytics | |
VIMTA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VIMTA LABS | 9% |
-27.6% |
5.2% |
| SENSEX | 1.5% |
-2.3% |
9.5% |
You may also like the below Video Courses